Efficacy and safety of bortezomib in patients with refractory and relapsed multiple myeloma (MM) outside clinical trials: Results from the catalan myeloma/amyloid study group (Gemmac)

被引：0
|
作者：
Cibeira, M. T.
Garcia, A.
Rosinol, L.
Petit, J.
Oriol, A.
Abella, E.
Soler, J. A.
Plensa, E.
Callis, M.
Gonzalez, Y.
Macia, J.
Orriols, J.
Escoda, L.
Tutusaus, M.
Heras, G.
Monzo, S.
Herranz, M. J.
Garcia, M.
Sureda, A.
Blade, J.
机构：
[1] Hosp Clin Barcelona, Barcelona, Spain
[2] H Germans Trias Pujol, Badalona, Spain
[3] H Mar Barcelona, Barcelona, Spain
[4] H Vall Hebron Barcelona, Barcelona, Spain
[5] H Josep Trueta Girona, Girona, Spain
[6] H Joan XXIII Tarragona, Althaia Xarxa Assistencial Manresa, Tarragona, Spain
[7] H Joan XXIII, Tarragona, Spain
[8] H Sagrat Cor Barcelona, Barcelona, Spain
[9] H Santa Tecla, Tarragona, Spain
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：157 / 157
页数：1
相关论文
共 50 条
  • [1] Safety and Efficacy of Bortezomib in Refractory/Relapsed Multiple Myeloma
    Lalagianni, C. E.
    Neokleous, N.
    Vadikoliou, C.
    Papalexandri, A.
    Apostolou, C.
    Saloum, R.
    Anagnostopoulos, A.
    Fassas, A.
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 : S26 - S26
  • [2] Bortezomib in patients with relapsed-refractory multiple myeloma (MM). Clinical observations.
    Kyrtsonis, MC
    Sachanas, S
    Vassilakopoulos, TP
    Kafassi, N
    Tzenou, T
    Papadogiannis, A
    Kalpadakis, C
    Antoniadis, AG
    Dimopoulou, MN
    Angelopoulou, MK
    Siakantaris, MP
    Dimitriadou, EM
    Kokoris, SI
    Plata, E
    Tsaftaridis, P
    Panayiotidis, P
    Pangalis, GA
    BLOOD, 2005, 106 (11) : 382B - 382B
  • [3] EFFICACY AND SAFETY OF BORTEZOMIB PLUS DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Sanchez, R. Garcia
    Saldana, R.
    Caparros, I.
    Gallardo, A.
    Garcia-Delgado, R.
    Rosell, A.
    Campos, A.
    de Llano, M. P. Queipo
    Perez, I.
    Moreno, M. J.
    Del Castillo, S.
    De la Torre, S.
    Ramirez, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 500 - 500
  • [4] CLINICAL EFFICACY OF VELCADE (BORTEZOMIB) AND DEXAMETHASONE THERAPY IN PATIENTS WITH REFRACTORY OR RELAPSED MULTIPLE MYELOMA
    Ionita, I.
    Cheveresan, M.
    Calamar, D.
    Ionita, C.
    Oros, D.
    Ionita, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 627 - 628
  • [5] Bortezomib in relapsed or refractory multiple myeloma:: results in a cohort of 39 patients
    Canovas Fernandez, A.
    Alonso Alonso, J. J.
    Barreiro Garcia, J. G.
    Aguirre Errasti, C.
    REVISTA CLINICA ESPANOLA, 2008, 208 (04): : 187 - 192
  • [6] Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials
    Lakshman, Arjun
    Abeykoon, Jithma P.
    Kumar, Shaji K.
    Rajkumar, S. Vincent
    Dingli, David
    Buadi, Francis K.
    Gonsalves, Wilson I.
    Leung, Nelson
    Dispenzieri, Angela
    Kourelis, Taxiarchis V.
    Go, Ronald S.
    Lacy, Martha Q.
    Hobbs, Miriam A.
    Lin, Yi
    Warsame, Rahma
    Lust, John
    Fonder, Amie L.
    Hwa, Yi L.
    Hayman, Suzanne R.
    Russell, Stephen J.
    Kyle, Robert A.
    Gertz, Morie A.
    Kapoor, Prashant
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (11) : 1146 - 1155
  • [7] Safety and efficacy of daratumumab in combination with bortezomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma
    Shinsuke Iida
    Tatsuo Ichinohe
    Atsushi Shinagawa
    Kenshi Suzuki
    Naoki Takezako
    Masayuki Aoki
    International Journal of Hematology, 2018, 107 : 460 - 467
  • [8] Safety and efficacy of daratumumab in combination with bortezomib and dexamethasone in Japanese patients with relapsed or refractory multiple myeloma
    Iida, Shinsuke
    Ichinohe, Tatsuo
    Shinagawa, Atsushi
    Suzuki, Kenshi
    Takezako, Naoki
    Aoki, Masayuki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2018, 107 (04) : 460 - 467
  • [9] Clinical Outcome of Bortezomib Retreatment in Patients with Relapsed or Refractory Multiple Myeloma
    Ahn, Jae-Sook
    Jung, Sung-Hoon
    Lee, Seung-Shin
    Ahn, Seo-Yeon
    Yang, Deok-Hwan
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    Lee, Je-Jung
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [10] Efficacy and Safety of the Panobinostat-Bortezomib-Dexamethasone Combination in Relapsed or Relapsed/Refractory Multiple Myeloma: Results from the Randomized Panorama 3 Study
    Laubach, Jacob P.
    Schjesvold, Fredrik
    Mariz, Mario
    Dimopoulos, Meletios A.
    Lech-Maranda, Ewa
    Spicka, Ivan
    Hungria, Vania T. M.
    Shelekhova, Tatiana
    Abdo, Andre
    Jacobasch, Lutz
    Polprasert, Chantana
    Hajek, Roman
    Illes, Arpad
    Wrobel, Tomasz
    Balari, Anna Sureda
    Beksac, Meral
    Goncalves, Iara
    Creixenti, Joan Blade
    Rajkumar, S. Vincent
    Chari, Ajai
    Lonial, Sagar
    Spencer, Andrew
    Maison-Blanche, Pierre
    Moreau, Philippe
    Richardson, Paul G.
    San-Miguel, Jesus F.
    BLOOD, 2020, 136
12345